Johnson & Johnson in charts: Innovative medicine growth offsets Stelara drag in Q3; U.S. sales rise 9.1% Y/Y
Johnson & Johnson in charts: Innovative medicine growth offsets Stelara drag in Q3; U.S. sales rise 9.1% Y/Y
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
Johnson & Johnson in charts: Innovative medicine growth offsets Stelara drag in Q3; U.S. sales rise 9.1% Y/Y